DR. AGARWAL'S EYE HOSP L Financial Ratios
DRAGARWQ · Healthcare · Current price ₹5,356.5
P/E ratio
46.1x
P/B ratio
7.2x
ROE
26.2%
ROCE
18.0%
Debt / Equity
1.59
Dividend yield
0.1%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 46.1x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 7.2x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 26.2% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 18.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 1.59 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with DR. AGARWAL'S EYE HOSP L's latest numbers.
DR. AGARWAL'S EYE HOSP L profitability
DR. AGARWAL'S EYE HOSP L generates a return on equity of 26.2% and a return on capital employed of 18.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 1.59 and a P/E of 46.1x, DR. AGARWAL'S EYE HOSP L is carrying meaningful debt. Our overall business-quality score for the company is 5.1 / 10.
Understand the ratios
More on DR. AGARWAL'S EYE HOSP L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.